Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States

Myelofibrosis (MF) is a chronic myeloproliferative neoplasm with a prevalence of 4 to 6 per 100,000 people in the USA. Treatment recommendations are risk-adapted. This study was conducted to evaluate how physicians risk-stratify patients at the time of MF diagnosis, the accuracy of the risk stratifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstovsek, Srdan, Yu, Jingbo, Kish, Jonathan K., Paranagama, Dilan, Kaufman, Jill, Myerscough, Callan, Grunwald, Michael R., Colucci, Philomena, Mesa, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536164/
https://www.ncbi.nlm.nih.gov/pubmed/32382773
http://dx.doi.org/10.1007/s00277-020-04055-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536164/
https://www.ncbi.nlm.nih.gov/pubmed/32382773
http://dx.doi.org/10.1007/s00277-020-04055-w

Ejemplares similares